Michael Witcher
- Aging top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 8
- Protein Degradation and Inhibitors 8
- Genomics and Chromatin Dynamics 8
- RNA modifications and cancer 7
- Cancer-related gene regulation 4
- DNA Repair Mechanisms 3
- Hematology top 10%
- Cancer Research top 10%
-
- PARP inhibition in cancer therapy 7
-
- interferon and immune responses 3
- Co-authors
- Tatiana ShorstovaBeverly M. EmersonWilliam D. FoulkesMaud MarquesKhalid HilmiTiejun ZhaoMaïka JangalHiep D. Le
- Journals
- Cancer Research (4 papers)Nucleic Acids Research (3 papers)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2 papers)
- Partner nations
- CanadaUnited StatesSingapore
In The Last Decade
Michael Witcher
37 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Aging 54
- Molecular Biology 1.3k
- Endocrine and Autonomic Systems 123
- Hematology 124
- Cancer Research 165
Countries citing papers authored by Michael Witcher
This map shows the geographic impact of Michael Witcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Witcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Witcher more than expected).
Fields of papers citing papers by Michael Witcher
This network shows the impact of papers produced by Michael Witcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Witcher. The network helps show where Michael Witcher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Witcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2022 | 10 | |
| 5 | 2021 | 13 | |
| 6 | Achieving clinical success with BET inhibitors as anti-cancer agentsbreakdown → | 2021 | 224 |
| 7 | 2020 | 9 | |
| 8 | 2020 | 84 | |
| 9 | 2019 | 52 | |
| 10 | 2018 | 70 | |
| 11 | 2018 | 25 | |
| 12 | 2017 | 59 | |
| 13 | 2016 | 24 | |
| 14 | 2016 | 149 | |
| 15 | 2016 | 37 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 25 | |
| 18 | 2012 | 4 | |
| 19 | 2009 | 188 | |
| 20 | 2007 | 10 |
About Michael Witcher
Michael Witcher is a scholar working on Molecular Biology, Hematology and Oncology, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Protein Degradation and Inhibitors (8 papers), Genomics and Chromatin Dynamics (8 papers), RNA modifications and cancer (7 papers), PARP inhibition in cancer therapy (7 papers), Cancer-related gene regulation (4 papers), interferon and immune responses (3 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Aging (54 citations), Molecular Biology (1.3k citations) and Endocrine and Autonomic Systems (123 citations). Michael Witcher has collaborated with scholars based in Canada, United States and Singapore. Frequent co-authors include Tatiana Shorstova, Beverly M. Emerson, William D. Foulkes, Maud Marques, Khalid Hilmi, Tiejun Zhao, Maïka Jangal, Hiep D. Le, Satchidananda Panda and Luciano DiTacchio. Their work appears in journals such as Cancer Research, Nucleic Acids Research, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Blood and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.